header
Image from OpenLibrary

Serum hepcidin levels in chronic hepatitis C patients / Alaa Mohamed Elamir Farag ; Supervised Nouman Elgarem , Amany Abdelmaqsoud Sholkamy , Alkhatib Kadry Alkemary

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Alaa Mohamed Elamir Farag , 2014Description: 104 P. : facsimiles ; 25cmOther title:
  • مستوى الهيبسيدين فى الدم فى مرضى التهاب الكبد الوبائى سى [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine Summary: Patients with chronic hepatitis C (CHC) often have increased liver iron, a condition associated with reduced sustained response to antiviral therapy, more rapid progression to cirrhosis, and development of hepatocellular carcinoma. The hepatic hormone hepcidin is the major regulator of iron metabolism and inhibits iron absorption and recycling from erythrophagocytosis. but studies in humans have been hampered so far by the lack of reliable quantitative assays for the 25 amino acid bioactive peptide in serum (s- hepcidin). The aim of this study was to evaluate the role of iron regulatory hormone hepcidin, in chronic HCV infected patients
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2014.Al.S (Browse shelf(Opens below)) Not for loan 01010110064607000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2014.Al.S (Browse shelf(Opens below)) 64607.CD Not for loan 01020110064607000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine

Patients with chronic hepatitis C (CHC) often have increased liver iron, a condition associated with reduced sustained response to antiviral therapy, more rapid progression to cirrhosis, and development of hepatocellular carcinoma. The hepatic hormone hepcidin is the major regulator of iron metabolism and inhibits iron absorption and recycling from erythrophagocytosis. but studies in humans have been hampered so far by the lack of reliable quantitative assays for the 25 amino acid bioactive peptide in serum (s- hepcidin). The aim of this study was to evaluate the role of iron regulatory hormone hepcidin, in chronic HCV infected patients

Issued also as CD

There are no comments on this title.

to post a comment.